Cargando…

PS82. Does Serum Amyloid ß-Protein predict the Response to Antidepressant treatment in Major Depression?

Detalles Bibliográficos
Autores principales:	Inoue, Megumi, Baba, Hajime, Shimano, Takahisa, Ishijima, Satoko, Suzuki, Toshihito, Arai, Heii
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616679/ http://dx.doi.org/10.1093/ijnp/pyw043.082

Ejemplares similares

PS157. Impact of benzodiazepine on cognition of remitted depression
por: Ishijima, Satoko, et al.
Publicado: (2016)

PS95. Cognitive impairment of remitted depression in medication with anticholinergic activity
por: Maeshima, Hitoshi, et al.
Publicado: (2016)

PS102. Apathy in elderly depression and the antidepressant response
por: Shimano, Takahisa, et al.
Publicado: (2016)

Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression
por: Nomoto, Hiroshi, et al.
Publicado: (2015)

Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population
por: Shibata, Nobuto, et al.
Publicado: (2011)

PS internal dump S.S. 93
por: Szeless, B
Publicado: (1975)

Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission
por: Aoki, Yumi, et al.
Publicado: (2022)

Exosomes as Carriers of Alzheimer's Amyloid-ß
por: Yuyama, Kohei, et al.
Publicado: (2017)

PS129. Low TNFAIP3 was normalized with antidepressant in patients with major depressive disorder
por: Hung, Yi-Yung
Publicado: (2016)

Amyloid-ß-directed immunotherapy for Alzheimer's disease
por: Lannfelt, L, et al.
Publicado: (2014)

Memorandum: Operation of S82 (Experiment on $\eta_{00} / \eta_{+-}$). P.S. energy
por: CERN. Geneva, et al.
Publicado: (1970)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Cognitive trajectories of patients with focal ß-amyloid deposition
por: Kim, Si Eun, et al.
Publicado: (2021)

Alignment of human aquaporin 4 and ß‐amyloid proteins may indicate involvement of ß‐amyloid in brain water homeostasis and prevention of brain edema
por: Lehrer, Steven, et al.
Publicado: (2023)

PS76. Effect of antidepressant therapy on white matter in patients with first-episode major depressive disorder
por: Lee, Chun-Te, et al.
Publicado: (2016)

PS188. Predict value of functional topological features for early response to antidepressant treatment in major depressive disorder
por: Hou, Zhenghua, et al.
Publicado: (2016)

Identification of BACE2 as an avid ß-amyloid-degrading protease
por: Abdul-Hay, Samer O, et al.
Publicado: (2012)

Genetic or Psychogenic? A Case Study of “Folie à Quatre” Including Twins
por: Ohnuma, Tohru, et al.
Publicado: (2015)

Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in Japan
por: Kobayashi, Hiroyuki, et al.
Publicado: (2018)

Antidepressant Advisor (ADeSS): a decision support system for antidepressant treatment for depression in UK primary care – a feasibility study
por: Harrison, Phillippa, et al.
Publicado: (2023)

Some notes concerning the new DC inflector For the SS 26 of the PS
por: Weiss, M
Publicado: (1966)

Some notes concerning the new DC inflector For the SS 26 of the PS
por: Weiss, M
Publicado: (1966)

LRP1 plays a major role in the amyloid-β clearance in microglia
por: N’Songo, Aurelie, et al.
Publicado: (2013)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

Activation of JNK Signaling Mediates Amyloid-ß-Dependent Cell Death
por: Tare, Meghana, et al.
Publicado: (2011)

Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
por: Kline, Adam
Publicado: (2012)

Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting
por: Plissonneau, Marie, et al.
Publicado: (2016)

Decreased CSF Levels of ß-Amyloid in Patients With Cortical Superficial Siderosis
por: Catak, Cihan, et al.
Publicado: (2019)

Application of (82)Sr/(82)Rb generator in neurooncology
por: Kostenikov, Nikolay A., et al.
Publicado: (2019)

G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer’s disease pathology
por: C, Rani Cathrine., et al.
Publicado: (2020)

PS78. Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder
por: Cho, Se Hoon, et al.
Publicado: (2016)

Study protocol for the antidepressant advisor (ADeSS): a decision support system for antidepressant treatment for depression in UK primary care: a feasibility study
por: Harrison, Phillippa, et al.
Publicado: (2020)

Teaterårsboken 82.
Publicado: (1982)

PS246. Psychological Dependence on Antidepressants in Patient with Panic Disorder: A Cross-Sectional Study
por: Fujii, Kazuhito, et al.
Publicado: (2016)

A high-purity $^{82}$Sr/$^{82}$Rb generator
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1990)

Correction: G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer’s disease pathology
por: Chellappa, Rani Cathrine, et al.
Publicado: (2021)

Major PS Contracts
Publicado: (1955)

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

PS121. Evaluation of extrapyramidal side effects in the treatment of behavioral and psychological symptoms of dementia (BPSD): Interactions between anti-Alzheimer drugs and antidepressants
por: Shimizu, Saki, et al.
Publicado: (2016)

PS110. Reversal of stress-induced anhedonia by the multimodel antidepressant, vortioxetine
por: Christensen, AK, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_64dt7ijpdh4t1aq2r5jks89u7q